PTEN and endometrial cancer: Conversely, there was a significant increase in the expression of gene proteins related to PTEN in the combined dosage groups, suggesting that the addition of P4 can effectively inhibit endometrial hyperplasia, while treating genitourinary syndrome of menopause (GSM) and improve the potential to prevent endometrial cancer.